The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.
Source: FDA Press Releases
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.